{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:31:26Z","timestamp":1787841086584,"version":"build-2784847793"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Adjuvant chest wall radiation therapy for postmastectomy breast cancer patients is highly effective in reducing the risk of locoregional recurrence. Hypofractionated regimen is increasingly being adopted in adjuvant radiotherapy. One of the reasons for its slow adoption is the concern that a hypofractionated regimen can lead to higher side effects, such as radiation-induced dermatitis. Even while modern techniques like intensity-modulated radiotherapy (IMRT) and three-dimensional conformal radiotherapy (3DCRT) have made great strides in protecting healthy tissues, the use of two-dimensional treatments with a telecobalt machine is still prevalent in many parts of developing countries like India. Hence, we conducted a retrospective study of the incidence and severity of radiation-induced dermatitis in breast cancer patients undergoing hypofractionated chest wall radiation therapy on a telecobalt machine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>1. To evaluate acute skin reaction in patients treated with chest wall hypofractionated adjuvant radiation in carcinoma of the breast on a telecobalt machine. 2. To evaluate the incidence of severity of odynophagia. 3. To evaluate the weight change during treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>In this retrospective study, we analyzed the data from postmodified radical mastectomy (PMRM) breast cancer patients treated with adjuvant chest wall radiotherapy using a hypofractionated regimen on a telecobalt machine at our hospital from 2017 to 2023 after institutional ethical committee approval. One hundred and fifty-six patients were treated with a hypofractionated regimen during this time period. The hypofractionated radiation schedule used was 40 Gy in 15 fractions with 2.66 Gy per fraction over 3 weeks, with 5 fractions per week on a telecobalt machine. Patient demographics, disease characteristics, treatment details, comorbidities, and skin reactions during treatment were retrieved from patient records and analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In our study, 148 (89.74%) patients had no skin reaction, and 16 patients had grade I radiation induced dermatitis during first week. During second week 88 (56.41%) patients had no skin reaction and 70 (56.41%) patients had grade I radiation induced dermatitis During third week, 137 (87.82%) patients had grade 1 and 9 (5.76%) patients developed grade 2 radiation induced dermatitis. None of the patient had grade III or IV radiation dermatitis during the treatment. During week 1 no patients had odynophagia and during week 2, grade 1 and 2 odynophagia was observed in 3 and 2 patients, respectively. Grade I odynophagia was observed in 16 patients and grade 2 odynophagia was documented in 9 patients during 3\n                      <jats:sup>rd<\/jats:sup>\n                      week of treatment and none of the patients had significant weight loss during treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Our study demonstrates that hypofractionated adjuvant chest wall radiation therapy using a telecobalt machine is associated with a low incidence of severe acute skin reactions and odynophagia. The regimen appears to be well-tolerated, with minimal impact on weight and nutritional status.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_109_25","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:05:54Z","timestamp":1774875954000},"page":"20-26","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of acute skin reactions in hypofractionated chest wall irradiation on a telecobalt machine for breast cancer"],"prefix":"10.4103","volume":"22","author":[{"given":"G. N.","family":"Manjunath","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Sri Devaraj Urs Academy of Higher Education and Research, Kolar, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Krishna","family":"Raj","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Father Muller Medical College, Mangalore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santhosha","family":"Kulal","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Sri Devaraj Urs Academy of Higher Education and Research, Kolar, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"R1-20260331","doi-asserted-by":"crossref","first-page":"e1027","DOI":"10.1016\/S2214-109X(20)30215-1","article-title":"Global burden and trends in premenopausal and postmenopausal breast cancer: A population-based study","volume":"8","author":"Heer","year":"2020","journal-title":"Lancet Glob Health"},{"key":"R2-20260331","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R4-20260331","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0167-8140(00)00204-8","article-title":"Adjuvant radiotherapy for breast cancer significantly improves overall survival: The missing link","volume":"55","author":"Van de Steene","year":"2000","journal-title":"Radiother Oncol"},{"key":"R5-20260331","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/jnci\/djh013","article-title":"The breast conserving surgery project breast-conserving surgery with or without radiotherapy: Pooled analysis for risks of ipsilateral breast tumour recurrence and mortality","volume":"96","author":"Vin-Hungh","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R6-20260331","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.ijrobp.2008.10.080","article-title":"ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncology-breast","volume":"73","author":"Taylor","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R7-20260331","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1056\/NEJMct0803525","article-title":"Radiation therapy for early-stage breast cancer after breast-conserving surgery","volume":"360","author":"Buchholz","year":"2009","journal-title":"N Engl J Med"},{"key":"R8-20260331","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1470-2045(08)70077-9","article-title":"The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial","volume":"9","author":"Bentzen","year":"2008","journal-title":"Lancet Oncol"},{"key":"R9-20260331","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0140-6736(08)60348-7","article-title":"The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial","volume":"371","author":"Bentzen","year":"2008","journal-title":"Lancet"},{"key":"R10-20260331","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1470-2045(06)70699-4","article-title":"Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: Long-term results of a randomised trial","volume":"7","author":"Owen","year":"2006","journal-title":"Lancet Oncol"},{"key":"R11-20260331","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/jnci\/94.15.1143","article-title":"Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer","volume":"94","author":"Whelan","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"R12-20260331","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2005.01.005","article-title":"Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: Long-term results of a randomised trial","volume":"75","author":"Yarnold","year":"2005","journal-title":"Radiother Oncol"},{"key":"R13-20260331","first-page":"XC5","article-title":"A study on dosimetric outcomes and acute toxicity of post mastectomy adjuvant hypofractionated radiotherapy for breast cancer","volume":"10","author":"Deshmukh","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"R14-20260331","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R15-20260331","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1470-2045(18)30813-1","article-title":"Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: A randomised, non-inferiority, open-label, phase 3 trial","volume":"20","author":"Wang","year":"2019","journal-title":"Lancet Oncol"},{"key":"R16-20260331","first-page":"452","article-title":"Comparison of result and outcome of conventional and hypofractionated radiotherapy in post-operative breast cancer patients","volume":"7","author":"Das","year":"2018","journal-title":"Int J Med Sci Public Health"},{"key":"R17-20260331","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/apjon.apjon_46_17","article-title":"A Comparative study of hypofractionated and conventional radiotherapy in postmastectomy breast cancer patients","volume":"5","author":"Rastogi","year":"2018","journal-title":"Asia Pac J Oncol Nurs"},{"key":"R18-20260331","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.adro.2017.10.007","article-title":"Predictors of radiation-induced acute skin toxicity in breast cancer at a single institution: Role of fractionation and treatment volume","volume":"3","author":"Parekh","year":"2017","journal-title":"Adv Radiat Oncol"},{"key":"R19-20260331","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1016\/j.clbc.2021.09.008","article-title":"Hypofractionated Radiation Therapy (HFRT) of breast\/chest wall and regional nodes in locally advanced breast cancer: Toxicity profile and survival outcomes in retrospective monoistitutional study","volume":"22","author":"De Matteis","year":"2022","journal-title":"Clin Breast Cancer"},{"key":"R20-20260331","first-page":"313","article-title":"Acute radiation dermatitis in breast cancer patients: Challenges and solutions","volume":"9","author":"Kole","year":"2017","journal-title":"Breast Cancer (Dove Med Press)"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_109_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:41:50Z","timestamp":1787838110000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_109_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_109_25","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-01-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}